US biotech to apply artificial intelligence to UK genome study

A DNA double helix is seen in an undated artist’s illustration released by the National Human Genome Research Institute to Reuters on May 15, 2012. Reuters/National Human Genome Research Institute/Handout Berg, a private company that uses artificial intelligence to discover new drugs and diagnostics, will help England’s national genomics project mine DNA and health data from thousands of British citizens for potential drug targets.Berg, based in Boston, was co-founded in 2006 by Silicon Valley real estate billionaire Carl Berg. Since then, it has been working to change the way drugs are discovered, working in partnership with key players such as the U.S. Department of Defense and the Parkinson’s Institute Clinical Center.Its newest agreement is with the Genomics England 100,000 Genomes Project, which aims to accelerate development of new diagnostics and…


Link to Full Article: US biotech to apply artificial intelligence to UK genome study